Arkolith/Insider Trading/LAB/Form 4

Casdin Partners GP, LLC

Director, 10% OwnerSTANDARD BIOTOOLS INC. (LAB) · full profile →Form 4 · filed Nov 26, 2025
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Buy(P)7.5M$1.30$9.8M71.8M
Nov 24, 2025Buy(P)150K$1.43$215K64.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-25-007187) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML